Close Menu

NEW YORK — Immunodiagnostics firm Avioq recently announced that it has received CE marking for its VioOne HIV Profile supplemental assay and has begun marketing the test in the European Union and other geographies that recognize the designation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.